"There is absolutely no doubt that the NHS will have to adapt to an evolving landscape if it is to continue to deliver world-class healthcare"
In Conversation
"No other country has grown cannabis at an industrial level before and we are well positioned to both develop and export best practices globally. We have…
With the initiation of a study on how to implement a national pharmacare program, we are hopeful that this may represent an opportunity to finally have…
"Portugal offers tremendous market access challenges which act as a learning curve for career development. As mentioned, the market is tricky to navigate but that can…
"The government has approved more innovative medicines in the past two years than the combined total reached during the period from 2010-2015; roughly 60 in 2017…
"Overall, we are interested in partners who are passionate about meeting the needs of these patients: it is not easy money and resources must be allocated…
"We recognize that there is an enormous amount to do in arthritis, but also recognize that we cannot do it on our own. As a result,…
"J&J therefore remains the largest single foreign investor in life sciences in the UK"
"At the moment, eight out of ten patients in Spain consider generics a valuable alternative to branded products"
"We are unique, however, because we not only provide the test results, which are after all just reports, but we can also create a personalised treatment…
"Hikal’s successful track record as a reliable and quality supplier to the crop sciences industry gave us our entry into the pharmaceutical sector, as Big Pharma…
"Gujarat was the first state in India to set up a pioneering, cloud-based e-governance system which has since then been rolled out across 16 states, covering…
